1. Unraveling survivin expression in chronic myeloid leukemia: Molecular interactions and clinical implications
   Paula Sabbo Bernardo et al, 2020, Blood Reviews CrossRef
2. Clinicopathological and Prognostic Significance of Inhibitor of Apoptosis Protein (IAP) Family Members in Lung Cancer: A Meta-Analysis
   Stephen Fung et al, 2021, Cancers CrossRef
3. Meta-analysis of P53 expression and sensitivity to platinum-based chemotherapy in patients with non-small cell lung cancer
   Sheng Lin et al, 2021, Medicine CrossRef
4. Association between epidermal growth factor receptor gene mutation status and short‑term efficacy of first‑line platinum‑containing chemotherapy in advanced non‑small cell lung cancer
   Lin Chen et al, 2022, Biomedical Reports CrossRef
5. First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC
   Pierre Peterlin et al, 2024, Expert Review of Anticancer Therapy CrossRef
6. Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas
   Toshiyuki Sumi et al, 2018, International Journal of Oncology CrossRef
7. SMAC Mimetics for the Treatment of Lung Carcinoma: Present Development and Future Prospects
   Ruchi Pandey et al, 2024, Mini-Reviews in Medicinal Chemistry CrossRef
8. Targeting survivin for therapeutic discovery: past, present, and future promises
   Robert C. Peery et al, 2017, Drug Discovery Today CrossRef
9. Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc
   Yufang Zuo et al, 2017, Molecular Medicine Reports CrossRef
10. HMGB1 Enhances Drug Resistance and Promotes In Vivo Tumor Growth of Lung Cancer Cells
    Hong Zheng et al, 2016, DNA and Cell Biology CrossRef
11. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia
    Yock-Ping Chow et al, 2017, BMC Cancer CrossRef
12. Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding
    Huifang Peng et al, 2017, Oncotarget CrossRef
13. Survivin Small Molecules Inhibitors: Recent Advances and Challenges
    Najah Albadari et al, 2023, Molecules CrossRef
14. Exploring the Anticancer Potential of Origanum majorana Essential Oil Monoterpenes Alone and in Combination against Non-Small Cell Lung Cancer
    Kholoud Arafat et al, 2023, Nutrients CrossRef
15. Expression of Molecular Markers in Primary Sites and Metastatic Lymph Nodes of Lung Cancer Patients
    Jie Li et al, 2017, Medical Science Monitor CrossRef
16. Knockdown of PARP6 or survivin promotes cell apoptosis and inhibits cell invasion of colorectal adenocarcinoma cells
    Haipeng Wang et al, 2017, Oncology Reports CrossRef